NeuroSpectrum Insights
About NeuroSpectrum Insights
NeuroSpectrum Insights is a medical device company that leverages AI to enhance the diagnosis of neurological and neurodevelopmental disorders. Their flagship product, GyriCalc, is a patented software solution designed to assist physicians in diagnosing autism. It achieves this by identifying early structural markers of neurodevelopmental differences through the automated measurement and analysis of MRI images. The company’s technology has demonstrated high accuracy, with reports indicating up to 94% accuracy in identifying autism.
NeuroSpectrum Insights aims to address the inefficiencies in current diagnostic processes, such as long waitlists and subjective evaluations, by providing an objective and accessible diagnostic tool.5 months after submission. While their initial focus is on autism diagnosis in the United States and Canada, NeuroSpectrum Insights plans to expand its brain analysis software algorithms to support clinicians in diagnosing other neurological conditions, including dyslexia, ADHD, and schizophrenia. They project to generate over $40 million in annual revenue in 2029.
For physicians, NeuroSpectrum Insights offers a tool that can potentially shorten the time to diagnosis for neurodevelopmental conditions like autism, accelerating access to critical therapeutic interventions. The software analyzes structural MRIs, providing data-driven results that can aid in objective diagnosis, even in children as young as nine months old. This technology could be particularly valuable in addressing the shortage of diagnosticians and the subjective nature of traditional diagnostic processes, ultimately leading to earlier and more appropriate treatment for patients.
Focus Areas
Business Intelligence
| Technology | GyriCalc software, AI-powered computerized analysis, structural MRI analysis, cerebral cortex analysis, surface characteristics analysis, Local Gyrification Index algorithm (C++), web application (Django/React) for DICOM upload, processing, and clinical reporting |
What Physicians Need to Know
NeuroSpectrum Insights offers physicians a tool for earlier and more objective diagnosis of autism and potentially other neurodevelopmental disorders, moving beyond subjective behavioral observations. GyriCalc's FDA clearance and high accuracy rates (over 90%) in identifying structural brain markers from MRIs can significantly shorten the diagnostic timeline, allowing for earlier intervention and potentially better patient outcomes. This technology can be particularly valuable in addressing the shortage of diagnosticians and the inefficiencies of traditional diagnostic processes. While currently focused on autism, the underlying technology may expand to other neurological conditions like dyslexia, ADHD, and schizophrenia. Physicians should note that while GyriCalc has received FDA marketing clearance, it has not yet received FDA clearance for diagnostic use.
GyriCalc is designed to integrate with existing MRI imaging workflows, accepting DICOM format as input. It provides segmented images and morphometric reports, which can be incorporated into clinical assessments. The software is compatible with 3D T1 MRI scans. The company's focus on a software-as-a-medical-device (SaMD) approach suggests potential for seamless integration into digital healthcare ecosystems.
Videos
News, demos, and interviews about NeuroSpectrum Insights.
Videos load interactively. If none appear, search YouTube for NeuroSpectrum Insights →
Frequently Asked Questions
Related Companies
Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]
Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]
Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]
Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]
Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]
